-
Signature
-
/s/ Rosty Raykov
-
Issuer symbol
-
FENC
-
Transactions as of
-
28 Feb 2026
-
Net transactions value
-
-$84,260
-
Form type
-
4
-
Filing time
-
03 Mar 2026, 16:05:04 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Raykov Rosty |
Director |
C/O FENNEC PHARMACEUTICALS, INC., PO BOX 13628, 68 TW ALEXANDER DRIVE, RESEARCH TRIANGLE PARK |
/s/ Rosty Raykov |
03 Mar 2026 |
0001468316 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
FENC |
Common shares |
Options Exercise |
$38,215 |
+15,598 |
+16% |
$2.45 |
114,075 |
02 Mar 2026 |
Direct |
F1 |
| transaction |
FENC |
Common shares |
Sale |
$84,260 |
-10,079 |
-8.8% |
$8.36 |
103,996 |
02 Mar 2026 |
Direct |
F2 |
| transaction |
FENC |
Common shares |
Award |
$0 |
+5,208 |
+5% |
$0.000000 |
109,204 |
28 Feb 2026 |
Direct |
F3 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
FENC |
Stock Options |
Options Exercise |
$38,215 |
-15,598 |
-0.97% |
$2.45 |
1,587,390 |
02 Mar 2026 |
options |
15,598 |
$2.45 |
Direct |
F4 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: